Prescription drug · ANDA
Cartia XT (diltiazem hydrochloride) NDC 62037-597
Diltiazem hydrochloride 120 mg/1 · Capsule, Extended release · Oral · Actavis Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62037-597-05 | 62037059705 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62037-597-05)Marketed from Jun 23, 1999 | |
| 62037-597-90 | 62037059790 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62037-597-90)Marketed from Jun 23, 1999 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cartia XTSuffix: XT
- Generic name (nonproprietary)
- diltiazem hydrochloride
- Active ingredients
- Diltiazem hydrochloride — 120 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Labeler
- Actavis Pharma, Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074752
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
- Identifiers
- Product ID 62037-597_cf6e0dbd-317f-430e-909d-5dd9e5a59f6bSPL ID cf6e0dbd-317f-430e-909d-5dd9e5a59f6bSPL set ID 2dc2b889-8443-4f7f-83be-86c68e179804RxCUI 830801, 830837, 830845, 830861, 831226, 831255, 831309, 831338UNII OLH94387TEUPC 0362037598906, 0362037599903, 0362037597909, 0362037600906
- Pharmacologic class
- Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462037059705followed by a unit qualifier and the quantityPackage 62037-0597-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Diltiazem hydrochloride extended-release capsules (once-a-day dosage) are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Diltiazem hydrochloride extended-release capsules (once-a-day dosage) are indicated for the management of chronic stable angina and angina due to coronary artery spasm.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 074752
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cartia XTdiltiazem hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | DirectRx | 72189-344 |
| Cartia XTdiltiazem hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | Bryant Ranch Prepack | 71335-0879 |
| Cartia XTdiltiazem hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 62037-598 |
| Cartia XTdiltiazem hydrochloride | Diltiazem hydrochloride 240 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 62037-599 |
| Cartia XTdiltiazem hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 62037-600 |
| Cartia XTdiltiazem hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | Bryant Ranch Prepack | 63629-7896 |